BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors

Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells

1993 • 141 citations

Differential inhibition of HLA-D- or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human Ia-like determinants.

1982 • 135 citations

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

1994 • 98 citations

T-cell responses against products of oncogenes: Generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides

1992 • 61 citations

Binding of BCR/ABL junctional peptides to major histocompatibility complex (MHC) class I molecules: studies in antigen-processing defective cell lines.

1994 • 42 citations

Characterization of peptides bound to extracellular and intracellular HLA-DR1 molecules

1993 • 40 citations

B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation.

1993 • 37 citations

Blood cell transplantation: report from an International Consensus Meeting.

1994 • 23 citations

Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-? (wellferon)

1989 • 22 citations

Use of interferon in the treatment of chronic myelogenous leukemia.

1994 • 14 citations

Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.

1994 • 6 citations

PRETREATMENT OF CHRONIC MYELOGENOUS LEUKEMIC BLOOD SAMPLES WITH CYTOSINE ARABINOSIDE PRIOR TO MIXED LYMPHOCYTE CULTURE TYPING

1988 • 4 citations

Cited By (0)

Loading...